BIO Financial Statements From 2010 to 2024

BKYI Stock  USD 1.59  0.05  3.05%   
BIO Key financial statements provide useful quarterly and yearly information to potential BIO Key International investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on BIO Key financial statements helps investors assess BIO Key's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting BIO Key's valuation are summarized below:
Gross Profit
3.4 M
Profit Margin
(1.06)
Market Capitalization
M
Enterprise Value Revenue
0.6691
Revenue
8.6 M
We have found one hundred twenty available fundamental signals for BIO Key International, which can be analyzed and compared to other ratios and to its rivals. Traders should compare all of BIO Key International prevailing fundamentals against the fundamentals between 2010 and 2024 to make sure the company is sustainable this year. The current Market Cap is estimated to decrease to about 5.2 M. Enterprise Value is estimated to decrease to about 4.7 M

BIO Key Total Revenue

5.04 Million

Check BIO Key financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BIO main balance sheet or income statement drivers, such as Interest Expense of 157.9 K, Selling General Administrative of 5.1 M or Total Revenue of 5 M, as well as many exotic indicators such as Price To Sales Ratio of 0.74, Ptb Ratio of 0.63 or Book Value Per Share of 14.82. BIO financial statements analysis is a perfect complement when working with BIO Key Valuation or Volatility modules.
  
This module can also supplement BIO Key's financial leverage analysis and stock options assessment as well as various BIO Key Technical models . Check out the analysis of BIO Key Correlation against competitors.

BIO Key Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets10.2 M13.7 M10.1 M
Slightly volatile
Short and Long Term Debt Total2.3 MM1.9 M
Pretty Stable
Other Current Liabilities968.8 K908.2 K614.8 K
Slightly volatile
Total Current Liabilities3.1 M4.2 M2.4 M
Slightly volatile
Property Plant And Equipment Net224.3 K350.5 K216.2 K
Slightly volatile
Accounts Payable638.2 K1.3 M663 K
Slightly volatile
CashMM2.8 M
Slightly volatile
Non Current Assets Total5.2 M2.9 M3.8 M
Slightly volatile
Non Currrent Assets Other478.3 K503.4 K4.5 M
Slightly volatile
Cash And Short Term Investments2.1 MM2.8 M
Slightly volatile
Common Stock Total Equity6697044.9 K
Slightly volatile
Common Stock Shares Outstanding382.6 K517.5 K517.9 K
Very volatile
Liabilities And Stockholders Equity10.2 M13.7 M10.1 M
Slightly volatile
Inventory5.8 M5.6 M1.7 M
Slightly volatile
Other Current Assets357.3 K376.1 K843.8 K
Very volatile
Other Stockholder Equity147.4 M140.4 M85.3 M
Slightly volatile
Total Liabilities4.8 M4.4 M2.6 M
Slightly volatile
Property Plant And Equipment Gross224.3 K350.5 K216.2 K
Slightly volatile
Total Current Assets11.3 M10.8 M6.7 M
Slightly volatile
Short Term DebtM1.9 M681.1 K
Slightly volatile
Common Stock7868275.4 K
Slightly volatile
Net Receivables1.6 M1.8 M1.3 M
Slightly volatile
Other Assets317 K333.7 K343.5 K
Pretty Stable
Property Plant Equipment240.4 K371.8 K219.3 K
Slightly volatile
Current Deferred Revenue395.4 K416.2 K438.2 K
Pretty Stable
Other Liabilities57.5 K60.6 K162.5 K
Slightly volatile
Intangible Assets2.7 M1.6 MM
Pretty Stable
Capital Surpluse88.3 M137.8 M85 M
Slightly volatile
Non Current Liabilities Other345.7 K355.5 K329.6 K
Slightly volatile
Capital Stock8528271.2 K
Slightly volatile
Capital Lease Obligations304.2 K177.7 K470.2 K
Slightly volatile
Short and Long Term Debt1.2 M1.7 MM
Slightly volatile

BIO Key Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Expense157.9 K166.2 K436.9 K
Pretty Stable
Selling General Administrative5.1 M8.5 M4.6 M
Slightly volatile
Total RevenueM9.1 M4.2 M
Slightly volatile
Other Operating Expenses8.9 M9.7 MM
Slightly volatile
Research Development2.3 M2.4 M1.7 M
Slightly volatile
Cost Of Revenue1.6 M2.9 M1.8 M
Slightly volatile
Total Operating Expenses7.5 M9.7 M6.4 M
Slightly volatile
Extraordinary Items240 K270 K294 K
Slightly volatile
Interest Income5.7 KK67.5 K
Slightly volatile
Selling And Marketing Expenses1.8 MM2.2 M
Slightly volatile
Preferred Stock And Other Adjustments628.7 K692.2 K770.2 K
Slightly volatile
Reconciled Depreciation712.4 K551.6 K1.2 M
Slightly volatile

BIO Key Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash FlowM2.8 M2.6 M
Slightly volatile
Depreciation623 K551.6 K479.8 K
Slightly volatile
End Period Cash Flow208.8 K219.8 K2.5 M
Pretty Stable
Stock Based Compensation462.6 K296.4 K461.9 K
Slightly volatile
Change To Netincome791.8 K833.4 K1.1 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.740.78727
Slightly volatile
Inventory Turnover0.460.4924.3869
Slightly volatile
Days Of Inventory On HandK995487
Very volatile
Payables Turnover2.051.662.9623
Pretty Stable
Sales General And Administrative To Revenue0.671.190.8824
Slightly volatile
Research And Ddevelopement To Revenue0.250.26371.1887
Slightly volatile
Cash Per Share11.736.738.752
Slightly volatile
Capex To Operating Cash Flow0.02210.01510.0339
Slightly volatile
Days Payables Outstanding217228572
Slightly volatile
Income Quality0.450.472.5096
Slightly volatile
Intangibles To Total Assets0.170.15120.2656
Pretty Stable
Current Ratio1.71.822.795
Slightly volatile
Receivables Turnover5.085.134.775
Pretty Stable
Graham Number14510683.8876
Slightly volatile
Revenue Per Share16.217.949.8
Slightly volatile
Interest Debt Per Share5.475.755.8577
Pretty Stable
Debt To Assets0.20.210.2345
Pretty Stable
Dividend Yield0.00280.00270.0024
Slightly volatile
Days Sales Outstanding99.6573.57103
Very volatile
Average Payables518.6 K691.2 K640.8 K
Pretty Stable
Stock Based Compensation To Revenue0.0880.04970.1158
Slightly volatile
EV To Sales0.670.71727
Slightly volatile
Average Inventory4.6 M4.4 M1.7 M
Slightly volatile
Average Receivables487.5 K513.2 K1.4 M
Slightly volatile
Days Of Payables Outstanding217228572
Slightly volatile
Ebt Per Ebit1.00.9588.0047
Slightly volatile
Quick Ratio1.260.821.9224
Pretty Stable
Net Income Per E B T0.580.940.9186
Pretty Stable
Cash Ratio0.90.511.3353
Pretty Stable
Days Of Inventory OutstandingK995487
Very volatile
Free Cash Flow Operating Cash Flow Ratio1.121.171.0508
Pretty Stable
Fixed Asset Turnover31.4520.7337.832
Slightly volatile
Capital Expenditure Coverage Ratio64.9268.33371
Very volatile
Debt Ratio0.20.210.2345
Pretty Stable
Price Sales Ratio0.740.78727
Slightly volatile
Asset Turnover0.580.530.9296
Slightly volatile
Operating Cycle1.1 K1.1 K588
Very volatile
Days Of Sales Outstanding99.6573.57103
Very volatile

BIO Key Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap5.2 M5.5 M80.2 M
Slightly volatile
Enterprise Value4.7 MM76.1 M
Slightly volatile

BIO Fundamental Market Drivers

Cash And Short Term Investments2.6 M

BIO Upcoming Events

29th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About BIO Key Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include BIO Key income statement, its balance sheet, and the statement of cash flows. BIO Key investors use historical funamental indicators, such as BIO Key's revenue or net income, to determine how well the company is positioned to perform in the future. Although BIO Key investors may use each financial statement separately, they are all related. The changes in BIO Key's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on BIO Key's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on BIO Key Financial Statements. Understanding these patterns can help to make the right decision on long term investment in BIO Key. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue416.2 K395.4 K
Total Revenue9.1 MM
Cost Of Revenue2.9 M1.6 M
Sales General And Administrative To Revenue 1.19  0.67 
Research And Ddevelopement To Revenue 0.26  0.25 
Revenue Per Share 17.94  16.20 
Stock Based Compensation To Revenue 0.05  0.09 
Capex To Revenue(0.01)(0.01)
Ebit Per Revenue(0.07)(0.07)
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BIO Key in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BIO Key's short interest history, or implied volatility extrapolated from BIO Key options trading.

Pair Trading with BIO Key

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BIO Key position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BIO Key will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to BIO Key could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BIO Key when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BIO Key - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BIO Key International to buy it.
The correlation of BIO Key is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BIO Key moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BIO Key International moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BIO Key can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether BIO Key International offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BIO Key's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Key International Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Key International Stock:
Check out the analysis of BIO Key Correlation against competitors.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Complementary Tools for BIO Stock analysis

When running BIO Key's price analysis, check to measure BIO Key's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIO Key is operating at the current time. Most of BIO Key's value examination focuses on studying past and present price action to predict the probability of BIO Key's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BIO Key's price. Additionally, you may evaluate how the addition of BIO Key to your portfolios can decrease your overall portfolio volatility.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Commodity Directory
Find actively traded commodities issued by global exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
CEOs Directory
Screen CEOs from public companies around the world
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Is BIO Key's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIO Key. If investors know BIO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIO Key listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(19.62)
Revenue Per Share
17.484
Quarterly Revenue Growth
0.323
Return On Assets
(0.27)
Return On Equity
(1.26)
The market value of BIO Key International is measured differently than its book value, which is the value of BIO that is recorded on the company's balance sheet. Investors also form their own opinion of BIO Key's value that differs from its market value or its book value, called intrinsic value, which is BIO Key's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIO Key's market value can be influenced by many factors that don't directly affect BIO Key's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BIO Key's value and its price as these two are different measures arrived at by different means. Investors typically determine if BIO Key is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIO Key's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.